Double-blind Trial Vitamin D and Covid 19
The results of the first randomised, controlled, double-blind trial vitamin D and Covid 19 have been released.
This was a small pilot study however the results point strongly in the direction of the usefulness of vitamin D
76 patients with confirmed Covid 19 admitted to hospital who also had confirmed viral pneumonia were split into two groups.
- One group was treated with vitamin D
- One group was not treated with vitamin D.
- Both groups received up-to-date Covid 19 treatment.The outcome measures assessed were:
Admission to the intensive care (ICU)
- 50 patients were given vitamin D – on the day of admission, on day3 and 7 of their hospital stay and each week weekly until either admitted to UCU or discharged from hospital.
- 26 patients did not have vitamin D.
- Neither patient nor doctors were aware who was receiving vitamin D. .
- Of the 50 patients treated with vitamin D
- One person ( 2%) required ICU admission.
- None died
- All were discharged without complications
- Of the 26 untreated patients
- 13 (50%) required ICU admission.
- 2 Died
- 11 were discharged
Comment: This is a small study but it seems pretty obvious what course of action one ought to take!